307 related articles for article (PubMed ID: 23062024)
1. Effect of aminoalkyl methacrylate copolymer E/HCl on in vivo absorption of poorly water-soluble drug.
Yoshida T; Kurimoto I; Yoshihara K; Umejima H; Ito N; Watanabe S; Sako K; Kikuchi A
Drug Dev Ind Pharm; 2013 Nov; 39(11):1698-705. PubMed ID: 23062024
[TBL] [Abstract][Full Text] [Related]
2. Aminoalkyl methacrylate copolymers for improving the solubility of tacrolimus. I: Evaluation of solid dispersion formulations.
Yoshida T; Kurimoto I; Yoshihara K; Umejima H; Ito N; Watanabe S; Sako K; Kikuchi A
Int J Pharm; 2012 May; 428(1-2):18-24. PubMed ID: 22405967
[TBL] [Abstract][Full Text] [Related]
3. Improved oral absorption of tacrolimus by a solid dispersion with hypromellose and sodium lauryl sulfate.
Jung HJ; Ahn HI; Park JY; Ho MJ; Lee DR; Cho HR; Park JS; Choi YS; Kang MJ
Int J Biol Macromol; 2016 Feb; 83():282-7. PubMed ID: 26642839
[TBL] [Abstract][Full Text] [Related]
4. Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet.
Cho JH; Kim YI; Kim DW; Yousaf AM; Kim JO; Woo JS; Yong CS; Choi HG
Eur J Pharm Sci; 2014 Apr; 54():1-7. PubMed ID: 24388864
[TBL] [Abstract][Full Text] [Related]
5. Establishment of new preparation method for solid dispersion formulation of tacrolimus.
Yamashita K; Nakate T; Okimoto K; Ohike A; Tokunaga Y; Ibuki R; Higaki K; Kimura T
Int J Pharm; 2003 Nov; 267(1-2):79-91. PubMed ID: 14602386
[TBL] [Abstract][Full Text] [Related]
6. Supersaturatable formulations for the enhanced oral absorption of sirolimus.
Kim MS; Kim JS; Cho W; Cha KH; Park HJ; Park J; Hwang SJ
Int J Pharm; 2013 Mar; 445(1-2):108-16. PubMed ID: 23396259
[TBL] [Abstract][Full Text] [Related]
7. Preparation of extended release solid dispersion formulations of tacrolimus using ethylcellulose and hydroxypropylmethylcellulose by solvent evaporation method.
Tsunashima D; Yamashita K; Ogawara K; Sako K; Higaki K
J Pharm Pharmacol; 2016 Mar; 68(3):316-23. PubMed ID: 26773717
[TBL] [Abstract][Full Text] [Related]
8. Preparation and comparison of tacrolimus-loaded solid dispersion and self-microemulsifying drug delivery system by in vitro/in vivo evaluation.
Huo T; Tao C; Zhang M; Liu Q; Lin B; Liu Z; Zhang J; Zhang M; Yang H; Wu J; Sun X; Zhang Q; Song H
Eur J Pharm Sci; 2018 Mar; 114():74-83. PubMed ID: 29222025
[TBL] [Abstract][Full Text] [Related]
9. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of topically applied tacrolimus dissolved in Marinosolv, a novel aqueous eye drop formulation.
Siegl C; König-Schuster M; Nakowitsch S; Koller C; Graf P; Unger-Manhart N; Schindlegger Y; Kirchoff N; Knecht C; Prieschl-Grassauer E; Sipos W
Eur J Pharm Biopharm; 2019 Jan; 134():88-95. PubMed ID: 30465821
[TBL] [Abstract][Full Text] [Related]
11. Enhanced dissolution and bioavailability of biochanin A via the preparation of solid dispersion: in vitro and in vivo evaluation.
Han HK; Lee BJ; Lee HK
Int J Pharm; 2011 Aug; 415(1-2):89-94. PubMed ID: 21645596
[TBL] [Abstract][Full Text] [Related]
12. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
13. Development of valsartan-loaded gelatin microcapsule without crystal change using hydroxypropylmethylcellulose as a stabilizer.
Li DX; Yan YD; Oh DH; Yang KY; Seo YG; Kim JO; Kim YI; Yong CS; Choi HG
Drug Deliv; 2010 Jul; 17(5):322-9. PubMed ID: 20367177
[TBL] [Abstract][Full Text] [Related]
14. Enhanced oral bioavailability of novel mucoadhesive pellets containing valsartan prepared by a dry powder-coating technique.
Cao QR; Liu Y; Xu WJ; Lee BJ; Yang M; Cui JH
Int J Pharm; 2012 Sep; 434(1-2):325-33. PubMed ID: 22688251
[TBL] [Abstract][Full Text] [Related]
15. Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution.
Park YJ; Kwon R; Quan QZ; Oh DH; Kim JO; Hwang MR; Koo YB; Woo JS; Yong CS; Choi HG
Arch Pharm Res; 2009 May; 32(5):767-72. PubMed ID: 19471892
[TBL] [Abstract][Full Text] [Related]
16. Effect of stabilizer on the maximum degree and extent of supersaturation and oral absorption of tacrolimus made by ultra-rapid freezing.
Overhoff KA; McConville JT; Yang W; Johnston KP; Peters JI; Williams RO
Pharm Res; 2008 Jan; 25(1):167-75. PubMed ID: 17968635
[TBL] [Abstract][Full Text] [Related]
17. Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration.
Zhu Q; Guo T; Xia D; Li X; Zhu C; Li H; Ouyang D; Zhang J; Gan Y
J Pharm Pharmacol; 2013 Aug; 65(8):1107-17. PubMed ID: 23837579
[TBL] [Abstract][Full Text] [Related]
18. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
[TBL] [Abstract][Full Text] [Related]
19. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
20. Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug.
Nassar T; Rom A; Nyska A; Benita S
J Control Release; 2009 Jan; 133(1):77-84. PubMed ID: 18822327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
